Mohan Pankaj 4
4 · Outlook Therapeutics, Inc. · Filed Jan 17, 2019
Insider Transaction Report
Form 4
Mohan Pankaj
DirectorPresident & CEO10% Owner
Transactions
- Purchase
Common Stock
2019-01-15$0.68/sh+8,000$5,440→ 7,064,553 total
Holdings
- 492,753(indirect: By Spouse)
Common Stock
- 39,405(indirect: By Children)
Common Stock
- 86,956(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6649 - $0.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.